Synthesis of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-B-D-arabinofuranosyluracil (18F-FMAU)
AssigneeUniversity of Southern California
InventorsZibo Li, Hancheng Cai, Peter S. Conti
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Southern California
InventorsZibo Li, Hancheng Cai, Peter S. Conti
Estimating the term…
The present invention relates to methods of synthesizing 18F-FMAU. In particular, 18F-FMAU is synthesized using one-pot reaction conditions in the presence of Friedel-Crafts catalysts. The one-pot reaction conditions are incorporated into a fully automated cGMP-compliant radiosynthesis module, which results in a reduction in synthesis time and simplifies reaction conditions. The one-pot reaction conditions are also suitable for the production of 5-substituted thymidine or cytidine analogs. The products from the one-pot reaction (e.g. the labeled thymidine or cytidine analogs) can be used as probes for imaging tumor proliferative activity. More specifically, these [18F]-labeled thymidine or cytidine analogs can be used as a PET tracer for certain medical conditions, including, but not limited to, cancer disease, autoimmunity inflammation, and bone marrow transplant.
A method of synthesizing 2′-deoxy-2′-[18F]-fluoro-5-substituted-1-β-D-arabinofuranosyl-uracil or -cytosine compounds in a one-pot reaction comprising:
A method of synthesizing an [18F]-labeled 2′-deoxy-arabino 5-substituted or unsubstituted uracil or cytosine nucleoside in a one-pot reaction comprising:
A method of synthesizing 2′-deoxy-2′-[18F]-fluoro-5-substituted-1-β-D-arabinofuranosyl-uracil or -cytosine compounds in a one-pot reaction comprising:
Dependencies are inferred from the claim text.